Dose schedule and enhanced conversational recast treatment for children with specific language impairment

Christina N. Meyers-Denman, Elena M Plante

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Purpose: Dosage has been identified as an important element of treatment that may affect treatment efficacy. The purpose of this study was to examine the role of dose schedule for treatment of grammatical morphology deficits in children with specific language impairment (SLI). Method: Sixteen 4-to-5-year-old children with SLI participated in a 5-week intervention consisting of equivalent daily Enhanced Conversational Recast treatment (Plante et al., 2014) targeting grammatical morphology. Half of the children received treatment in one 30-min session (massed condition). Half received treatment in three 10-min sessions (spaced condition) within one 4-hr period. Progress was assessed 3 times weekly by probing a child’s use of his or her treatment morpheme and untreated morpheme (a maturational control) in untreated contexts. Results: Preto posttreatment morpheme usage differed significantly for children regardless of dosage condition, and pre to post usage of an untreated morpheme was unchanged, demonstrating overall treatment efficacy. There were no differences in treatment effects for the massed and spaced conditions. Conclusions: The study adds to evidence that Enhanced Conversational Recast can produce positive results in a short period of time for children with SLI. Furthermore, clinicians may have some flexibility in terms of the dose schedule they use to deliver this treatment in an evidencebased manner.

Original languageEnglish (US)
Pages (from-to)334-346
Number of pages13
JournalLanguage, Speech, and Hearing Services in Schools
Volume47
Issue number4
DOIs
StatePublished - Oct 1 2016

Fingerprint

Appointments and Schedules
Language
language
Therapeutics
Specific Language Impairment
Recasts
Dose
deficit
flexibility
Morpheme
evidence
Grammatical Morphology
Treatment Efficacy

ASJC Scopus subject areas

  • Medicine(all)
  • Language and Linguistics
  • Linguistics and Language
  • Speech and Hearing

Cite this

Dose schedule and enhanced conversational recast treatment for children with specific language impairment. / Meyers-Denman, Christina N.; Plante, Elena M.

In: Language, Speech, and Hearing Services in Schools, Vol. 47, No. 4, 01.10.2016, p. 334-346.

Research output: Contribution to journalArticle

@article{0eb961fda07842ed8d62defc3c76b4d3,
title = "Dose schedule and enhanced conversational recast treatment for children with specific language impairment",
abstract = "Purpose: Dosage has been identified as an important element of treatment that may affect treatment efficacy. The purpose of this study was to examine the role of dose schedule for treatment of grammatical morphology deficits in children with specific language impairment (SLI). Method: Sixteen 4-to-5-year-old children with SLI participated in a 5-week intervention consisting of equivalent daily Enhanced Conversational Recast treatment (Plante et al., 2014) targeting grammatical morphology. Half of the children received treatment in one 30-min session (massed condition). Half received treatment in three 10-min sessions (spaced condition) within one 4-hr period. Progress was assessed 3 times weekly by probing a child’s use of his or her treatment morpheme and untreated morpheme (a maturational control) in untreated contexts. Results: Preto posttreatment morpheme usage differed significantly for children regardless of dosage condition, and pre to post usage of an untreated morpheme was unchanged, demonstrating overall treatment efficacy. There were no differences in treatment effects for the massed and spaced conditions. Conclusions: The study adds to evidence that Enhanced Conversational Recast can produce positive results in a short period of time for children with SLI. Furthermore, clinicians may have some flexibility in terms of the dose schedule they use to deliver this treatment in an evidencebased manner.",
author = "Meyers-Denman, {Christina N.} and Plante, {Elena M}",
year = "2016",
month = "10",
day = "1",
doi = "10.1044/2016_LSHSS-15-0064",
language = "English (US)",
volume = "47",
pages = "334--346",
journal = "Language, Speech, and Hearing Services in Schools",
issn = "0161-1461",
publisher = "American Speech-Language-Hearing Association (ASHA)",
number = "4",

}

TY - JOUR

T1 - Dose schedule and enhanced conversational recast treatment for children with specific language impairment

AU - Meyers-Denman, Christina N.

AU - Plante, Elena M

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Purpose: Dosage has been identified as an important element of treatment that may affect treatment efficacy. The purpose of this study was to examine the role of dose schedule for treatment of grammatical morphology deficits in children with specific language impairment (SLI). Method: Sixteen 4-to-5-year-old children with SLI participated in a 5-week intervention consisting of equivalent daily Enhanced Conversational Recast treatment (Plante et al., 2014) targeting grammatical morphology. Half of the children received treatment in one 30-min session (massed condition). Half received treatment in three 10-min sessions (spaced condition) within one 4-hr period. Progress was assessed 3 times weekly by probing a child’s use of his or her treatment morpheme and untreated morpheme (a maturational control) in untreated contexts. Results: Preto posttreatment morpheme usage differed significantly for children regardless of dosage condition, and pre to post usage of an untreated morpheme was unchanged, demonstrating overall treatment efficacy. There were no differences in treatment effects for the massed and spaced conditions. Conclusions: The study adds to evidence that Enhanced Conversational Recast can produce positive results in a short period of time for children with SLI. Furthermore, clinicians may have some flexibility in terms of the dose schedule they use to deliver this treatment in an evidencebased manner.

AB - Purpose: Dosage has been identified as an important element of treatment that may affect treatment efficacy. The purpose of this study was to examine the role of dose schedule for treatment of grammatical morphology deficits in children with specific language impairment (SLI). Method: Sixteen 4-to-5-year-old children with SLI participated in a 5-week intervention consisting of equivalent daily Enhanced Conversational Recast treatment (Plante et al., 2014) targeting grammatical morphology. Half of the children received treatment in one 30-min session (massed condition). Half received treatment in three 10-min sessions (spaced condition) within one 4-hr period. Progress was assessed 3 times weekly by probing a child’s use of his or her treatment morpheme and untreated morpheme (a maturational control) in untreated contexts. Results: Preto posttreatment morpheme usage differed significantly for children regardless of dosage condition, and pre to post usage of an untreated morpheme was unchanged, demonstrating overall treatment efficacy. There were no differences in treatment effects for the massed and spaced conditions. Conclusions: The study adds to evidence that Enhanced Conversational Recast can produce positive results in a short period of time for children with SLI. Furthermore, clinicians may have some flexibility in terms of the dose schedule they use to deliver this treatment in an evidencebased manner.

UR - http://www.scopus.com/inward/record.url?scp=84992568297&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992568297&partnerID=8YFLogxK

U2 - 10.1044/2016_LSHSS-15-0064

DO - 10.1044/2016_LSHSS-15-0064

M3 - Article

C2 - 27701629

AN - SCOPUS:84992568297

VL - 47

SP - 334

EP - 346

JO - Language, Speech, and Hearing Services in Schools

JF - Language, Speech, and Hearing Services in Schools

SN - 0161-1461

IS - 4

ER -